Advanced Medical Isotope Corporation (OTCMKTS:RDGL) Sees Large Growth in Short Interest

Advanced Medical Isotope Corporation (OTCMKTS:RDGL) was the recipient of a large increase in short interest during the month of August. As of August 15th, there was short interest totaling 86,800 shares, anincreaseof886.4% from the July 31st total of 8,800 shares. Based on an average trading volume of 7,966,400 shares, the short-interest ratio is currently 0.0 days. Based on an average trading volume of 7,966,400 shares, the short-interest ratio is currently 0.0 days.

Advanced Medical Isotope Trading Down 3.9%

Shares of RDGL stock traded down $0.00 during trading hours on Tuesday, hitting $0.11. 773,972 shares of the company were exchanged, compared to its average volume of 1,189,930. Advanced Medical Isotope has a 1 year low of $0.04 and a 1 year high of $0.18. The firm has a fifty day moving average of $0.12 and a 200 day moving average of $0.12.

About Advanced Medical Isotope

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.